| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | VP, Finance &Strategy And CFO | VP, Corporate Development
2 companies
Desilva Nishan M is a VP, Finance &Strategy And CFO at LIGAND PHARMACEUTICALS INC with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 6 sells.
Estimated insider holdings value: $9.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 7,000 | $2.96 | $20,722.80 | New | -40.5% | -56.3% | |
| May 14, 2015 | LGND Ligand Pharmaceuticals Inc | VP, Finance &Strategy And CFO | Sale+OE | 68,363 | $83.91 | $5,736,515.82 | -38.0% | - | - | |
| Feb 10, 2015 | LGND Ligand Pharmaceuticals Inc | VP, Corporate Development | Sell | 2,300 | $56.34 | $129,582.00 | -12.3% | - | - |